Почетна › Хемофилија › Kalifornija
Kliničke studije za Хемофилија u državi Kalifornija
15 studija za Хемофилија traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Zvanični tekst studije (na engleskom)
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Children With Hemophilia A
- Loma Linda University Health, Loma Linda
Тражи се учесникОпсервациона студија
Узраст од 7 до 12 · Оба пола · Ажурирано 13. 11. 2026. · NCT07088458A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
- Center for Inherited Blood Disorders, Orange
- University of California San Francisco, San Francisco
- Kaiser Permanente, Vallejo
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 9. 11. 2026. · NCT07226206Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- University of California Davis Medical Center-Site Number: 8400005, Sacramento
Тражи се учесникФаза 4
Узраст 12 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06941870A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- UC Davis Cancer Center, Sacramento
Тражи се учесникФаза 1/2
Узраст од 2 до 59 · Мушкарци · Ажурирано 5. 11. 2026. · NCT05987449A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Center for Inherited Blood Disorders, Orange
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07416604A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- The Luskin Orthopaedic Institute for Children- Site Number : 8400013, Los Angeles
- Children's Hospital Los Angeles- Site Number : 8400002, Los Angeles
- The Center for Inherited Blood Disorders- Site Number : 8400009, Orange
- и још 1
Тражи се учесникФаза 3
Узраст од 1 до 11 · Мушкарци · Ажурирано 27. 10. 2026. · NCT07285460A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
- Altman Clinical and Translational Research Institute-IDS, La Jolla
- Altman Clinical and Translational Research Institute, La Jolla
- Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles
- и још 1
Тражи се учесникФаза 1
Узраст од 12 до 74 · Мушкарци · Ажурирано 15. 10. 2026. · NCT06703606Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Regents of the University of California||UC Davis Health, Rancho Cordova
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 7. 10. 2026. · NCT05568719A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Children's Hospital Los Angeles- Site Number : 8400005, Los Angeles
Тражи се учесникФаза 4
Узраст 12 и старији · Мушкарци · Ажурирано 23. 9. 2026. · NCT06145373Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 0 до 20 · Оба пола · Ажурирано 21. 8. 2026. · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- и још 5
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 17. 8. 2026. · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Stanford University, Palo Alto
- Rady Children's Hospital, San Diego
Тражи се учесникОпсервациона студија
Узраст од 6 до 19 · Оба пола · Ажурирано 2. 7. 2026. · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Children's Hospital Los Angeles, Los Angeles
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 60 · Оба пола · Ажурирано 2. 7. 2026. · NCT06349473Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD), Orange
- Stanford University: Stanford Children's Health, Redwood City
Тражи се учесникФаза 1
Узраст од 0 до 90 · Оба пола · Ажурирано 3. 4. 2026. · NCT05500807SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Orthopaedic Institute for Children, Los Angeles
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
Тражи се учесникФаза 4
Узраст од 12 до 100 · Оба пола · Ажурирано 12. 1. 2026. · NCT04647227Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.